Ontario individuals who are immunocompromised can get a fourth dose

by admin | Apr 19, 2024 | Article

Ontario individuals who are immunocompromised can get a fourth dose (booster) three months (84 days) after completion of the three-dose primary series. Please visit https://covid-19.ontario.ca/getting-covid-19-vaccine for more information.

Government of Canada signs new COVID-19 antibody therapy agreement

by admin | Apr 19, 2024 | Article

Please visit https://www.canada.ca/en/public-services-procurement/news/2022/02/government-of-canada-signs-new-covid-19-antibody-therapy-agreement.html for details.

Canadian Rheumatology Association Position Statement on COVID-19 Vaccination

by admin | Apr 19, 2024 | Article

Please visit https://rheum.ca/wp-content/uploads/2022/03/FINAL-Updated-PS-on-COVID-19-Vacc-March-25_2022_for-publication.pdf for details.

Canadian Rheumatology Association Improves Outcomes In SLE

by admin | Apr 19, 2024 | Article

As an initiative of the Canadian Rheumatology Association and endorsed by Lupus Canada and the Canadian Network of Improved Outcomes in SLE, the Canadian SLE Working Group has recently published new recommendations for the assessment and monitoring of lupus patients...

Lupus Canada is pleased to share that Health Canada has approved Evusheld for pre-exposure prophylaxis of COVID-19 in immune-compromised individuals.

by admin | Apr 19, 2024 | Article

Evusheld is now approved for use in adults and children (12 years of age and older, weighing at least 40 kg) who are not currently infected with COVID-19 and have not had recent known contact with someone infected with COVID-19, and: who are immune...